Clinical trial

Andosan in Allergic and Asthma Patients

NCT05192720

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-08-31

PhaseNA

Study timeline

Study start (actual)2021-08-31Date precision: day

Registry last updated2024-06-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Allergic Asthmaunresolved

Allergic Rhinoconjunctivitisunresolved

Immune Toleranceunresolved

Interventions

AndosanDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

University Hospital, Akershuslead sponsor

Oslo University Hospitalcollaborator

ImmunoPharma AScollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05192720 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.